Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews-Reference-Cited by-同舟云学术

Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews

Published:2019-09-27 Issue:6 Volume:26 Page:843-851
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Chande Nilesh¹²,Costello Samuel P³,Limketkai Berkeley N⁴,Parker Claire E⁵,Nguyen Tran M⁵,Macdonald John K¹²,Feagan Brian G¹²⁶

Affiliation:

1. Division of Gastroenterology, Department of Medicine, University of Western Ontario, London, Ontario, Canada

2. Cochrane IBD Group, University of Western Ontario, London, Ontario, Canada

3. Department of Gastroenterology, The Queen Elizabeth Hospital, Adelaide, Australia

4. Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California, USA

5. Robarts Clinical Trials Inc. London, Ontario, Canada

6. Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada

Abstract

The Cochrane IBD Group presented a symposium at Digestive Diseases Week 2018 entitled “Alternative and Complementary Approaches for the Treatment of IBD: Evidence from Cochrane Reviews.” This article summarizes the data presented at this symposium.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/26/6/843/33206040/izz223.pdf

Reference87 articles.

1. Patients’ views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?;Zeitz;Eur J Gastroenterol Hepatol.,2017

2. The information needs and preferences of persons with longstanding inflammatory bowel disease;Wong;Can J Gastroenterol.,2012

3. Patient education in inflammatory bowel disease: a patient-centred, mixed methodology study;McDermott;J Crohns Colitis.,2018

4. A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study;Raknes;Pharmacoepidemiol Drug Saf.,2017

5. Preferences for medical marijuana over prescription medications among persons living with chronic conditions: alternative, complementary, and tapering uses;Bruce;J Altern Complement Med.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Inflammatory Bowel Disease;Pediatrics;2022-12-22

2. Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives;Computational and Structural Biotechnology Journal;2022

3. Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis;Journal of Clinical Medicine;2021-03-01

4. Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews;Inflammatory Bowel Diseases;2021-01-16

5. Lactobacillus casei ATCC 393 and it's metabolites alleviate dextran sulphate sodium-induced ulcerative colitis in mice through the NLRP3-(Caspase-1)/IL-1β pathway;Food & Function;2021